Cost-Effectiveness of Smoking Cessation Approaches in Emergency Departments

被引:2
|
作者
Miller, Ted R. [1 ,2 ,12 ]
Johnson, Mark B. [1 ,2 ]
Dziura, James D. [3 ]
Weiss, June [3 ]
Carpenter, Kelly M. [4 ]
Grau, Lauretta E. [5 ]
V. Pantalon, Michael [3 ]
Abroms, Lorien [6 ]
Collins, Linda M. [7 ]
Toll, Benjamin A. [8 ,9 ]
Bernstein, Steven L. [10 ,11 ]
机构
[1] Pacific Inst Res & Evaluat, Beltsville, MD USA
[2] Curtin Univ, Sch Publ Hlth, Perth, WA, Australia
[3] Yale Sch Med, Dept Emergency Med, New Haven, CT USA
[4] Optum Ctr Wellbeing Res, Seattle, WA USA
[5] Yale Sch Med, Yale Ctr Implementat Sci, New Haven, CT USA
[6] Washington Univ, Dept Prevent, Washington, DC USA
[7] NYU, Sch Global Publ Hlth, New Haven, CT USA
[8] Yale Canc Ctr, New Haven, CT USA
[9] Med Univ South Carolina, Charleston, SC USA
[10] Dartmouth Hitchcock Med Ctr, Lebanon, NH USA
[11] Dartmouth Geisel Sch Med, Hanover, NH USA
[12] Pacific Inst Res & Evaluat, 4061 Powder Mill Rd,Suite 350, Beltsville, MD 20705 USA
关键词
D O I
10.1016/j.amepre.2023.01.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Americans of lower SES use tobacco products at disproportionately high rates and are over-represented as patients of emergency departments. Accordingly, emergency department visits are an ideal time to initiate tobacco treatment and aftercare for this vulnerable and understudied population. This research estimates the costs per quit of emergency department smokingcessation interventions and compares them with those of other approaches. Methods: Previously published research described the effectiveness of 2 multicomponent smoking line referral, and follow-up communication. Study 1 (collected in 2010-2012) only analyzed the combined interventions. Study 2 (collected in 2017-2019) analyzed the intervention components independently. Costs per participant and per quit were estimated separately, under distinct intervention with dedicated staff and intervention with repurposed staff assumptions. The distinction concerns whether the intervention used dedicated staff for delivery or whether time from existing staff was repurposed for intervention if available.Results: Data were analyzed in 2021-2022. In the first study, the cost per participant was $860 (2018 dollars), and the cost per quit was $11,814 (95% CI=$7,641, $25,423) (dedicated) and $227 per participant and $3,121 per quit (95% CI=$1,910, $7,012) (repurposed). In Study 2, the combined effect of brief negotiated interviewing, nicotine replacement therapy, and quitline cost $808 per participant and $6,100 per quit (dedicated) (95% CI=$4,043, $12,274) and $221 per participant and $1,669 per quit (95% CI=$1,052, $3,531) (repurposed).Conclusions: Costs varied considerably per method used but were comparable with those of other smoking cessation interventions. Am J Prev Med 2023;65(1):39-44.& COPY; 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [31] Cost-effectiveness of an intensive telephone-based intervention for smoking cessation
    Smith, Mark W.
    An, Lawrence C.
    Fu, Steven S.
    Nelson, David B.
    Joseph, Anne M.
    JOURNAL OF TELEMEDICINE AND TELECARE, 2011, 17 (08) : 437 - 440
  • [32] Cost-Effectiveness of Preoperative Smoking Cessation Interventions in Total Joint Arthroplasty
    Boylan, Matthew R.
    Bosco, Joseph A., III
    Slover, James D.
    JOURNAL OF ARTHROPLASTY, 2019, 34 (02): : 215 - 220
  • [33] A long term cost-effectiveness analysis model for smoking cessation in Korea
    Bae, J. Y.
    Song, H. J.
    Joe, K. H.
    Kim, C. H.
    Song, H. R.
    Ryu, G. C.
    Kim, D. J.
    Lee, E. K.
    VALUE IN HEALTH, 2008, 11 (03) : A275 - A275
  • [34] Smoking cessation for primary prevention of cardiovascular disease: A cost-effectiveness analysis
    Kinderen, AJD
    Oh, F
    De Laet, C
    VALUE IN HEALTH, 2004, 7 (06) : 692 - 693
  • [35] SMOKING-CESSATION ACROSS BORDERS: TRANSFERABILITY OF COST-EFFECTIVENESS RESULTS
    Vemer, P.
    Rutten-van Molken, M. P.
    VALUE IN HEALTH, 2008, 11 (06) : A459 - A459
  • [36] COST-EFFECTIVENESS OF A SMOKING CESSATION PROGRAM AFTER MYOCARDIAL-INFARCTION
    KRUMHOLZ, HM
    COHEN, BJ
    TSEVAT, J
    PASTERNAK, RC
    WEINSTEIN, MC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (06) : 1697 - 1702
  • [37] Behavioral interventions for smoking cessation during pregnancy: A cost-effectiveness analysis
    Bacheller, Hannah L.
    Hersh, Alyssa R.
    Caughey, Aaron B.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S713 - S714
  • [38] Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment
    Heitjan, D. F.
    Asch, D. A.
    Ray, Riju
    Rukstalis, Margaret
    Patterson, Freda
    Lerman, C.
    PHARMACOGENOMICS JOURNAL, 2008, 8 (06): : 391 - 399
  • [39] Cost-effectiveness of a specialized nursing smoking cessation unit in a tertiary hospital
    Antoran, Belen Ruiz
    Munoz, Trinidad
    Milan, Isabel
    Payares, Concepcion
    Serrano, Lucia
    Perez, Myriam Aguilar
    Ruiz, Rosa Malo de Molina
    Avendano-Sola, Cristina
    Gil, Piedad Ussetti
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [40] Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation
    Cromwell, J
    Bartosch, WJ
    Fiore, MC
    Hasselblad, V
    Baker, T
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (21): : 1759 - 1766